Nanjing Medlander Medical Technology Co. Ltd. A (688273) - Total Liabilities
Based on the latest financial reports, Nanjing Medlander Medical Technology Co. Ltd. A (688273) has total liabilities worth CN¥158.97 Million CNY (≈ $23.26 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Nanjing Medlander Medical Technology Co. Ltd. A - Total Liabilities Trend (2020–2024)
This chart illustrates how Nanjing Medlander Medical Technology Co. Ltd. A's total liabilities have evolved over time, based on quarterly financial data. See 688273 working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Nanjing Medlander Medical Technology Co. Ltd. A Competitors by Total Liabilities
The table below lists competitors of Nanjing Medlander Medical Technology Co. Ltd. A ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Zhejiang Meida Industrial Co Ltd
SHE:002677
|
China | CN¥139.50 Million |
|
Princess Private Equity Holding Ltd
LSE:PEY
|
UK | €108.45 Million |
|
Shanghai Sheng Jian Environment Technology Co Ltd
SHG:603324
|
China | CN¥1.72 Billion |
|
WA1 Resources Ltd
AU:WA1
|
Australia | AU$5.67 Million |
|
Hanilcmt Co Ltd
KO:300720
|
Korea | ₩1.14 Trillion |
|
Merida Industry Co Ltd
TW:9914
|
Taiwan | NT$15.38 Billion |
|
Zhejiang Unifull Industrial Fibre Co Ltd
SHE:002427
|
China | CN¥1.42 Billion |
|
Tyntek Corp
TW:2426
|
Taiwan | NT$972.75 Million |
Liability Composition Analysis (2020–2024)
This chart breaks down Nanjing Medlander Medical Technology Co. Ltd. A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 688273 market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 7.88 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.12 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.10 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Nanjing Medlander Medical Technology Co. Ltd. A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Nanjing Medlander Medical Technology Co. Ltd. A (2020–2024)
The table below shows the annual total liabilities of Nanjing Medlander Medical Technology Co. Ltd. A from 2020 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥199.66 Million ≈ $29.22 Million |
+25.89% |
| 2023-12-31 | CN¥158.60 Million ≈ $23.21 Million |
+11.72% |
| 2022-12-31 | CN¥141.96 Million ≈ $20.77 Million |
+22.38% |
| 2021-12-31 | CN¥116.01 Million ≈ $16.98 Million |
+30.81% |
| 2020-12-31 | CN¥88.69 Million ≈ $12.98 Million |
-- |
About Nanjing Medlander Medical Technology Co. Ltd. A
Nanjing Medlander Medical Technology Co.,Ltd. engages in the research and development, manufacture, sale, and service of pelvic floor rehabilitation equipment and related products in China and internationally. It offers pelvic floor and obstetrics and gynecology rehabilitation, reproductive rehabilitation product, and sports rehabilitation products, as well as consumables products, such as vagina… Read more